|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,73,100.00 KRW | -2.09% |
|
-1.98% | +0.42% |
| 07/07 | Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA | MT |
| 03/07 | South Korean Shares Jump on Bargain-Hunting, Chip Stock Gains | MT |
9
Listed companies
2
Private companies
70
Insiders
Relation chart of related listed companies: Celltrion, Inc.
Active Relations
Past Relations
Related listed companies: Celltrion, Inc.
Active Relations
Past Relations
Relationship chart for related private companies: Celltrion, Inc.
Active Relations
Past Relations
Related private companies: Celltrion, Inc.
Polus, Inc.
Pharmaceuticals: Other
Celltrion Healthcare Co., Ltd.
Biotechnology
Active Relations
Past Relations
Connection statistics
Active
Inactive
Listed companies
Private companies
Activities of related companies
| Pharmaceuticals: Major | 5 |
| Biotechnology | 2 |
| Pharmaceuticals: Other | 1 |
| Construction Materials | 1 |
| Aerospace & Defense | 1 |
| Wholesale Distributors | 1 |
Countries of related companies
| South Korea | 7 |
| United States | 3 |
| United Kingdom | 1 |
Employees
2,680
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















